Diabetes mellitus and cancer of the digestive organs: An Italian population-based cohort study

Journal of Diabetes and its Complications

Volumn 29, Issue 8, 2015, Pages 1056-1061

  Valent, Francesca ^a  

^a Epidemiological Service   (Italy)

Author keywords

Cancer; Cohort study; Diabetes mellitus; Metformin; Sulfonylureas; Thiazolidinediones

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; BUFORMIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLYMIDINE; METFORMIN; PHENFORMIN; SULFONYLUREA; ANTILIPEMIC AGENT;

ARTICLE; CANCER INCIDENCE; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; DIABETIC PATIENT; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE REGISTRY; ESOPHAGUS CANCER; FOLLOW UP; GALLBLADDER CANCER; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; ICD-9-CM; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; ITALY; LIVER CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RECTUM CANCER; RETROSPECTIVE STUDY; SMALL INTESTINE CANCER; STOMACH CANCER; ADULT; AGED; COMPARATIVE STUDY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HOSPITALIZATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK; VERY ELDERLY; YOUNG ADULT;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIGESTIVE SYSTEM NEOPLASMS; FEMALE; HOSPITALIZATION; HUMANS; HYPOLIPIDEMIC AGENTS; INCIDENCE; ITALY; LIVER NEOPLASMS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 84947611280     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2015.07.017     Document Type: Article

References (25)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 37 Suppl. 1 2014 S81 S90 10.2337/dc14-S081
2. Associazione Italiana Registri Tumori Schede tumori http://www.registri-tumori.it/cms/it/node/18 2015 (Accessed 21 Apr 2015)
3. Associazione Italiana Registri Tumori Registro tumori del Friuli Venezia Giulia http://www.registri-tumori.it/cms/RTFriuli 2015 (Accessed 21 Apr 2015)
4. C. Bosetti, V. Rosato, D. Buniato, A. Zambon, C. La Vecchia, and G. Corrao Cancer risk for patients using thiazolidinediones for type 2 diabetes: A meta-analysis The Oncologist 18 2 2013 148 156 10.1634/theoncologist.2012-0302
5. C. Bosetti, V. Rosato, J. Polesel, F. Levi, R. Talamini, M. Montella, and et al. Diabetes mellitus and cancer risk in a network of case-control studies Nutrition and Cancer 64 5 2012 643 651 10.1080/01635581.2012.676141
6. C.H. Chang, J.W. Lin, L.C. Wu, M.S. Lai, L.M. Chuang, and K.A. Chan Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus Hepatology 55 5 2012 1462 1472 10.1002/hep.25509
7. J.L. Chiang, M.S. Kirkman, L.M. Laffel, A.L. Peters, and Type 1 Diabetes Sourcebook Authors Type 1 diabetes through the life span: A position statement of the American Diabetes Association Diabetes Care 37 7 2014 2034 2054 10.2337/dc14-1140
8. V. Donadon, M. Balbi, P. Casarin, A. Vario, and A. Alberti Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin World Journal of Gastroenterology 14 37 2008 5695 5700
9. EpiCentro La Sorveglianza Passi Diabete Dati nazionali 2013 2013 (http://www.epicentro.iss.it/passi/dati/diabete.asp. Accesses 21 Apr 2015)
10. J.M. Evans, L.A. Donnelly, A.M. Emslie-Smith, D.R. Alessi, and A.D. Morris Metformin and reduced risk of cancer in diabetic patients BMJ 330 7503 2005 1304 1305
11. E.J. Gallagher, and D. LeRoith Diabetes, antihyperglycemic medications and cancer risk: Smoke or fire? Current Opinion in Endocrinology, Diabetes, and Obesity 20 5 2013 485 494 10.1097/01.med.0000433065.16918.83
12. J.L. Harding, J.E. Shaw, A. Peeters, B. Cartensen, and D.J. Magliano Cancer risk among people with type 1 and type 2 diabetes: Disentangling true associations, detection bias, and reverse causation Diabetes Care 38 2 2015 264 270 10.2337/dc14-1996
13. International Diabetes Federation IDF diabetes atlas 6th ed. 2013 (www.idf.org/diabetesatlas. Accessed 21 Apr 2015)
14. G. La Torre, A. Sferrazza, M.R. Gualano, C. de Waure, G. Clemente, A.M. De Rose, and et al. Investigating the synergistic interaction of diabetes, tobacco smoking, alcohol consumption, and hypercholesterolemia on the risk of pancreatic cancer: A case-control study in Italy BioMed Research International 2014 2014 481019 10.1155/2014/481019
15. H.C. Lin, Y.T. Hsu, B.H. Kachingwe, C.Y. Hsu, Y.S. Uang, and L.H. Wang Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: A six-year population-based cohort study Journal of Clinical Pharmacy and Therapeutics 39 4 2014 354 360 10.1111/jcpt.12151
16. M. Monami, C. Lamanna, D. Balzi, N. Marchionni, and E. Mannucci Sulphonylureas and cancer: A case-control study Acta Diabetologica 46 4 2009 279 284 10.1007/s00592-008-0083-2
17. A.A. Onitilo, J.M. Engel, I. Glurich, R.V. Stankowski, G.M. Williams, and S.A. Doi Diabetes and cancer II: Role of diabetes medications and influence of shared risk factors Cancer Causes and Control 23 7 2012 991 1008 10.1007/s10552-012-9971-4
18. J.E. Shaw, R.A. Sicree, and P.Z. Zimmet Global estimates of the prevalence of diabetes for 2010 and 2030 Diabetes Research and Clinical Practice 87 1 2010 4 14 10.1016/j.diabres.2009.10.007
19. S. Singh, P.P. Singh, A.G. Singh, M.H. Murad, R.R. McWilliams, and S.T. Chari Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: A systematic review and meta-analysis American Journal of Gastroenterology 108 4 2013 510 519 10.1038/ajg.2013.7 (quiz 520)
20. D. Soranna, L. Scotti, A. Zambon, C. Bosetti, G. Grassi, A. Catapano, and et al. Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: A meta-analysis The Oncologist 17 6 2012 813 822 10.1634/theoncologist.2011-0462
21. B. Thakkar, K.N. Aronis, M.T. Vamvini, K. Shields, and C.S. Mantzoros Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: A meta-analysis using primary data of published studies Metabolism 62 7 2013 922 934 10.1016/j.metabol.2013.01.014
22. K.K. Tsilidis, J.C. Kasimis, D.S. Lopez, E.E. Ntzani, and J.P. Ioannidis Type 2 diabetes and cancer: Umbrella review of meta-analyses of observational studies BMJ 350 2015 g7607 10.1136/bmj.g7607
23. F. Valent, S. Tillati, and L. Zanier Prevalence and comorbidities of known diabetes in northeastern Italy Journal of Diabetes Investigation 4 4 2013 355 360 10.1111/jdi.12043
24. Y.X. Yang, S. Hennessy, and J.D. Lewis Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients Gastroenterology 127 4 2004 1044 1050
25. H. Zhang, C. Gao, L. Fang, H.C. Zhao, and S.K. Yao Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: A meta-analysis Scandinavian Journal of Gastroenterology 48 1 2013 78 87 10.3109/00365521.2012.719926